Analysis of human B cell response to recombinant Leishmania LPG3.

[1]  I. Sharifi,et al.  Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine , 2014, PloS one.

[2]  Douglas E. Jones,et al.  An In Vitro Model of Antibody-Enhanced Killing of the Intracellular Parasite Leishmania amazonensis , 2014, PloS one.

[3]  M. Siddiqi,et al.  Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches , 2014, Front. Immunol..

[4]  J. Cano,et al.  Leishmaniasis Worldwide and Global Estimates of Its Incidence , 2012, PloS one.

[5]  S. Beverley,et al.  Innate Immune Activation and Subversion of Mammalian Functions by Leishmania Lipophosphoglycan , 2012, Journal of parasitology research.

[6]  D. Malvy,et al.  IgE Mediates Killing of Intracellular Toxoplasma gondii by Human Macrophages through CD23-Dependent, Interleukin-10 Sensitive Pathway , 2011, PloS one.

[7]  N. Safaee,et al.  Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis. , 2011, Experimental parasitology.

[8]  Sudhir Gupta,et al.  TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors , 2010, Journal of Clinical Immunology.

[9]  J. Cyster,et al.  CD69 Suppresses Sphingosine 1-Phosophate Receptor-1 (S1P1) Function through Interaction with Membrane Helix 4 , 2010, The Journal of Biological Chemistry.

[10]  J. Louis,et al.  Regulatory B Cells Shape the Development of Th2 Immune Responses in BALB/c Mice Infected with Leishmania major Through IL-10 Production , 2009, The Journal of Immunology.

[11]  R. Coler,et al.  Vaccines Against Leishmania , 2009 .

[12]  R. Ahmed,et al.  Requirement of B Cells for Generating CD4+ T Cell Memory1 , 2009, The Journal of Immunology.

[13]  A. Ponte-Sucre,et al.  Leishmania spp.: proficiency of drug-resistant parasites. , 2007, International journal of antimicrobial agents.

[14]  A. Khamesipour,et al.  Leishmaniasis vaccine candidates for development: a global overview. , 2006, The Indian journal of medical research.

[15]  Y. Belkaid,et al.  Uptake of Leishmania major by dendritic cells is mediated by Fcγ receptors and facilitates acquisition of protective immunity , 2006, The Journal of experimental medicine.

[16]  A. Bhan,et al.  A Case for Regulatory B Cells1 , 2006, The Journal of Immunology.

[17]  Michael P Barrett,et al.  Chemotherapy of trypanosomiases and leishmaniasis. , 2005, Trends in parasitology.

[18]  D. Mcmahon-Pratt,et al.  Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? , 2004, Immunological reviews.

[19]  David Gray,et al.  B cells regulate autoimmunity by provision of IL-10 , 2002, Nature Immunology.

[20]  S. Beverley,et al.  Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability , 2002, The EMBO journal.

[21]  C. Hunter,et al.  IL‐10 mediates susceptibility to Leishmania donovani infection , 2001, European journal of immunology.

[22]  J. M. Requena,et al.  Leishmania infantum: gene cloning of the GRP94 homologue, its expression as recombinant protein, and analysis of antigenicity. , 2000, Experimental parasitology.

[23]  T. Ilg.  Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana , 2000, The EMBO journal.

[24]  M. Roncarolo,et al.  A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.

[25]  V. Pistoia,et al.  Production of cytokines by human B cells in health and disease. , 1997, Immunology today.

[26]  S. Reiner,et al.  Efficient immunity against Leishmania major in the absence of interleukin-6 , 1997, Infection and immunity.

[27]  W. Solbach,et al.  B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. , 1996, Experimental parasitology.

[28]  P. Debré,et al.  The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Dalrymple,et al.  Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia , 1995, Infection and immunity.

[30]  H. Akuffo,et al.  Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells , 1993, Clinical and experimental immunology.

[31]  Wynn,et al.  In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. , 1993, The Journal of clinical investigation.

[32]  H. Akuffo,et al.  Contribution of non‐Leishmania‐specific immunity to resistance to Leishmania infection in humans , 1992, Clinical and experimental immunology.

[33]  B. Sherry,et al.  Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo , 1991, Infection and immunity.

[34]  F. Liew,et al.  Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. , 1990, Journal of immunology.

[35]  Gary J. Nabel,et al.  New Generation Vaccines , 1990 .

[36]  F. Liew,et al.  Tumour necrosis factor (TNFα) in leishmaniasis. I. TNFα mediates host protection against cutaneous leishmaniasis. , 1990 .

[37]  S. Beverley,et al.  Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. , 1998, Trends in microbiology.

[38]  V. Pistoia,et al.  Relationships Between B Cell Cytokine Production in Secondary Lymphoid Follicles and Apoptosis of Germinal Center B Lymphocytes , 1995, Stem cells.

[39]  J. Vilček,et al.  Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. , 1989, Laboratory investigation; a journal of technical methods and pathology.